Everything below concerns Nuclear receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-06-26. Numbers and descriptions here follow the published literature rather than marketing material.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516, GW-501516, GW 501516, endurobol | Names vary in research and anti-doping documents. |
| Chemical class | Synthetic PPARδ agonist | Small-molecule nuclear receptor ligand. |
| CAS Registry Number | 317318-70-0 | Identifier commonly associated with GW501516. |
| Appearance | White to off-white powder | Typical for purified research material. |
| Solubility | Low in water; soluble in DMSO and ethanol | Organic solvents are common for laboratory stock solutions. |
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
==== Resignation of Luis Barranzuela ==== Luis Barranzuela, the new Minister of the Interior, was a former police officer and the lawyer of Vladimir Cerrón until his appointment as minister. On 18 October 2021, Congress questioned the new minister over the 158 reprimands he got during his time as a police officer, and his ties to Free Peru. The parties Popular Action and Go on Country warned that they would not give confidence to the Vásquez cabinet if Luis Barranzuela wasn't removed from the cabinet. Despite pandemic restrictions established by the ministry he presided, Luis Barranzuela hosting a party for the Día de la Canción Criolla on 31 October 2021 at his home located in the district of Surco, in Lima. The party was attended by congressman Guillermo Bermejo, who upon being caught by the cameras of Latina Televisión fled the place in the van of his lawyer Ronald Atencio, who reportedly was another of the guests. Barrenzuela denied having a party and affirmed that it was only a work meeting, declaring that "Peru cannot stop". For his part, Bermejo declared that "the loud music was from an adjoining house". However, neighbors of Barranzuela declared to the local press that a party did take place, that it had started in the afternoon and that due to the discomfort of the loud music they decided to call the police. Interviewed by Perú21, a neighbor told that days before, cars on the streets around the minister's house had been removed, something unusual, which would suggest that the party had been planned.
== Career == In 2001, Strahl joined the University of North Carolina at Chapel Hill as an assistant professor in the Department of Biochemistry and Biophysics. He was promoted to associate professor in 2008 and full professor in 2014. He also holds an appointment at UNC’s Lineberger Comprehensive Cancer Center and is a faculty member in the Curriculum in Genetics and Molecular Biology. Additionally, Strahl also serves as the faculty director of the UNC High-Throughput Peptide Synthesis and Array Core Facility From 2016 to 2020, he served as the Vice Chair of the Department of Biochemistry & Biophysics at UNC. From 2020 to 2022, he stepped into the role of Interim Chair of Biochemistry and Biophysics. Since 2023, Strahl has held the position of Assistant Dean for Research in the Office of Research at the University of North Carolina School of Medicine. The primary mission of the Office of Research is to develop and implement a strategic plan for research in the School of Medicine(reference). The UNC School of Medicine selected Strahl as an Oliver Smithies Investigator in recognition of his research contributions. This annual award recognizes senior faculty members who have gained international recognition for their work. Since 2015, Strahl has directed UNC's Program on Chromatin and Epigenetics, aiming to understand the complex language of epigenetic regulation. The program seeks to advance human health and address diseases. Stahl is also co-founder of EpiCypher, Inc. – a company known for services for chromatin biology and epigenetics research.
=== Adhesive === As an adhesive, rabbit-skin glue is used in the production of the bellows of concertinas, and in other small, lightweight instruments—prominently in violins. Its supreme advantages are very fast bonding, and easy debonding with hot water to allow an instrument to be disassembled for internal repairs if needed. It also has very low creep, which is the tendency of some glues to plastically yield under even low but consistent stresses over time. For example, guitar bridges are subject to high lateral stresses that, with the wrong glue, can lead it to creep forward. The proteins of the glue soak into the wood and interlace with its pores. Setting of the glue occurs with cooling and drying, so the working time is very short, on the order of minutes, to stick the parts together and get full strength; by comparison, PVA glue might provide 20–30 minutes of working time. Since rabbit-skin glue only works by microscopically stitching the wood fibers together, any gaps in a joint will not be filled, so the mating surfaces must be very smooth to achieve successful adhesion.
During the late 18th and early 19th centuries, patients undergoing surgery were often administered laudanum and alcohol, and had their hands restrained and bodies held down while the operation was performed.
He added that exploring a different vocal palette enabled him to maintain a constant "tension" throughout a song, whereas previously he had alternated between a more relaxed singing style and some "tense" sporadic passages. Toufouti's vocals on Saddiction have been compared to those of Phil Collins. Ronny Bittner of Rock Hard adds that his "soulful singing" brings "some warmth" to the album's overall sound, "through skilful harmonic shifts".
Sources: en.wikipedia.org
Eager to join this enterprise, Humboldt postponed plans to visit North America, instead preparing to travel from Cuba to South America, crossing the Isthmus of Panama and the Andes to Lima. He wrote to Baudin, proposing to join the expedition and offering to continue his journey independently if necessary. Humboldt’s decision to return to South America was influenced by scientific opportunities, such as the chance to study the Andes’ environmental effects on plant life and to meet the botanist José Celestino Mutis in Bogotá. This return also allowed for consolidation of previous research findings. During his time in Havana, Humboldt encountered the Scottish botanist John Fraser and his son, who had survived a shipwreck. Humboldt assisted them and arranged for Fraser’s son to join him in Mexico, though the latter chose to return to London. Fraser agreed to take two cases of Humboldt’s botanical specimens to England for safekeeping until they could be sent to Berlin. From Havana, Humboldt and Bonpland prepared to sail to Cartagena or Portobello, depending on conditions, intent on continuing their scientific exploration of South America.
=== Volatile acidity === While volatile acidity (VA) is usually measured in terms of acetic acid content, its sensory perception is a combination of acetic (vinegary aromas) and ethyl acetate (nail polish remover and model airplane glue aromas). High levels of VA can inhibit wine yeast and may lead to a sluggish or stuck fermentation. Several microbes can be a source for VA, including Acetobacter, Brettanomyces, and film yeast such as Candida, as well as LAB. However, while LAB usually only produce acetic acid, these other microbes often produce ethyl acetate, as well as acetic acid. Most wine-producing countries have laws regulating the amount volatile acidity permitted for wine available for sale and consumption. In the United States, the legal limit is 0.9 g/L for foreign wine exported to the United States, 1.2 g/L for white table wine, 1.4 g/L for red wine, 1.5 g/L for white dessert wine, and 1.7 g/L for red dessert wine. European Union wine regulations limit VA to 1.08 g/L for white table wines and 1.20 g/L for red table wines. Heterofermenting species of Oenococcus and Lactobacillus have the potential to produce high levels of acetic acid through the metabolism of glucose, though with most strains of O. oeni, the amount is usually only 0.1 to 0.2 g/L. Several species of Pediococcus can also produce acetic acid through other pathways. Wines starting out with a high pH levels (above 3.5) stand the greatest risk of excessive acetic acid production due to the more favorable conditions for Lactobacillus and Pediococcus species. L.
=== Pusha T's solo career and work relationship with GOOD Music === Before releasing any solo material, Pusha T signed in the autumn of 2010 to GOOD Music, a record label founded by West. That year, he appeared on multiple songs in West's GOOD Fridays series, rapped in the GOOD cypher at the BET Hip Hop Awards, and had two features on West's album My Beautiful Dark Twisted Fantasy. The creative partnership was fruitful; Pusha T became president of GOOD in 2015, and West had production credits on all of his commercially released albums until It's Almost Dry. Pusha T was publicly outspoken about not seeing eye-to-eye with West on politics and career moves multiple times. Among other examples, he expressed disagreement over West's support of Donald Trump and claimed to have different principles on music industry relationships. The relationship had completely deteriorated by late 2022, after West made statements widely condemned as antisemitic. Pusha T said the following in response to West's comments: "It's definitely affected me. It's been disappointing. As a Black man in America, there is no room for bigotry or hate speech. So yeah. It's been very disappointing, let's talk straight." In another interview, he said: "It's beyond [wild stuff] and it's nothing to tap dance around. It's wrong. Period." and "He's not speaking to me now. If you ain't with it, you ain't down. And I ain't with it. I'm not budging on that. I'm not with it." He also clarified that he was no longer the president of GOOD or affiliated with the label in any way.
Aβ is the main component of the kind of amyloid plaques that form in the brains of people with Alzheimer's disease. Aβ can also form the deposits that line cerebral blood vessels in cerebral amyloid angiopathy. The plaques are composed of aggregated Aβ oligomers called amyloid fibrils, a protein fold shared by other peptides such as the prions associated with protein misfolding disease, also known as proteinopathy.
Sources: en.wikipedia.org
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.
No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.
Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.